ASHP to Update Guidelines on Preventing Controlled-Substances Diversion
In the midst of the COVID-19 pandemic, pharmacists and other healthcare professionals have had to find creative ways to combat the ongoing opioid epidemic. In 2017, the American Society of Health-System Pharmacists (ASHP) issued guidelines for preventing diversion of controlled substances, and the organization plans an update in 2021-2022 to help hospitals curb diversion. Read more.

Long-Term Medical Cannabis May Decrease Opioid Use and Improve Pain, Quality of Life
Although studies have demonstrated that cannabis diminishes pain and has opioid-sparing effects, large-scale longitudinal clinical studies on the effects of cannabis products on patients have yet to be performed. Results from a recent study revealed that using medical cannabis for 6 months reduces pain intensity and pain-related interference and improves quality of life. Read more.

Highlighting Strategies to Detect and Avert Drug Diversion
According to the U.S. Department of Health and Human Services, more than 130 individuals die from an opioid-related overdose each day. A recent article highlights key measures that healthcare professionals and organizations can implement to identify and thwart drug diversion. The article reviews the warning signs that may indicate diversion among healthcare professionals, as well as its impact on patients, healthcare workers, hospitals, and the general public. Read more.